223 related articles for article (PubMed ID: 23836088)
21. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation.
Leppert W; Zajaczkowska R; Wordliczek J
Expert Opin Pharmacother; 2019 Apr; 20(5):511-522. PubMed ID: 30625013
[TBL] [Abstract][Full Text] [Related]
22. Management of Opioid-Induced Constipation in Hospice Patients.
Sera L; McPherson ML
Am J Hosp Palliat Care; 2018 Feb; 35(2):330-335. PubMed ID: 28423917
[TBL] [Abstract][Full Text] [Related]
23. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
Earnshaw SR; Klok RM; Iyer S; McDade C
Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
[TBL] [Abstract][Full Text] [Related]
24. Opioid-induced constipation.
Wein S
J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186
[TBL] [Abstract][Full Text] [Related]
25. Management of opioid-induced constipation.
Prichard D; Norton C; Bharucha AE
Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
[TBL] [Abstract][Full Text] [Related]
26. [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].
Osterbrink J; Haas U
Wien Med Wochenschr; 2008; 158(21-22):621-6. PubMed ID: 19052708
[TBL] [Abstract][Full Text] [Related]
27. Lubiprostone for the treatment of opioid-induced bowel dysfunction.
Wong BS; Camilleri M
Expert Opin Pharmacother; 2011 Apr; 12(6):983-90. PubMed ID: 21385112
[TBL] [Abstract][Full Text] [Related]
28. Methylnaltrexone: treatment for opioid-induced constipation.
Licup N; Baumrucker SJ
Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
[TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Jansen JP; Lorch D; Langan J; Lasko B; Hermanns K; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
J Pain; 2011 Feb; 12(2):185-93. PubMed ID: 21292169
[TBL] [Abstract][Full Text] [Related]
30. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
31. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
Streicher JM; Bilsky EJ
J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
[TBL] [Abstract][Full Text] [Related]
32. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain.
Tuteja AK; Biskupiak J; Stoddard GJ; Lipman AG
Neurogastroenterol Motil; 2010 Apr; 22(4):424-30, e96. PubMed ID: 20100280
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology, diagnosis, and management of opioid-induced constipation.
Farmer AD; Holt CB; Downes TJ; Ruggeri E; Del Vecchio S; De Giorgio R
Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):203-212. PubMed ID: 29870734
[TBL] [Abstract][Full Text] [Related]
34. Management of opioid-induced bowel dysfunction in cancer patients.
Tamayo AC; Diaz-Zuluaga PA
Support Care Cancer; 2004 Sep; 12(9):613-8. PubMed ID: 15221581
[TBL] [Abstract][Full Text] [Related]
35. Investigational opioid antagonists for treating opioid-induced bowel dysfunction.
Mozaffari S; Nikfar S; Abdollahi M
Expert Opin Investig Drugs; 2018 Mar; 27(3):235-242. PubMed ID: 29266973
[TBL] [Abstract][Full Text] [Related]
36. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
37. Methylnaltrexone for opioid-induced constipation in advanced illness.
Sanz Rubiales A; del Valle Rivero ML
N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955
[No Abstract] [Full Text] [Related]
38. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.
Sawh SB; Selvaraj IP; Danga A; Cotton AL; Moss J; Patel PB
Mayo Clin Proc; 2012 Mar; 87(3):255-9. PubMed ID: 22386181
[TBL] [Abstract][Full Text] [Related]
39. Methylnaltrexone for opioid-induced constipation in advanced illness.
Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
[TBL] [Abstract][Full Text] [Related]
40. Oxycodone/naloxone in the management of patients with pain and opioid-induced bowel dysfunction.
Leppert W
Curr Drug Targets; 2014 Jan; 15(1):124-35. PubMed ID: 24020972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
